Mittie Doyle insider trades

Open-market stock purchases and sales by Mittie Doyle, Chief Medical Officer at Avalo Therapeutics, Inc, from SEC Form 4 filings since Mar 31, 2022.

Recent trades

DateStockTradeValue
Aug 28, 2026AVTX Avalo Therapeutics, IncSold$13.6K
Aug 28, 2026AVTX Avalo Therapeutics, IncBought (not open market)—
Aug 17, 2026AVTX Avalo Therapeutics, IncSold$20K
Aug 17, 2026AVTX Avalo Therapeutics, IncBought (not open market)—
Aug 10, 2026AVTX Avalo Therapeutics, IncBought (not open market)—
Aug 10, 2026AVTX Avalo Therapeutics, IncSold$13.6K
Jul 27, 2026AVTX Avalo Therapeutics, IncSold$20K
Jul 27, 2026AVTX Avalo Therapeutics, IncBought (not open market)—
Jun 23, 2026AVTX Avalo Therapeutics, IncSold$26.1K
Jun 23, 2026AVTX Avalo Therapeutics, IncBought (not open market)—
Jun 16, 2026CGEM Cullinan Therapeutics, IncBought (not open market)—
Jun 10, 2026AVTX Avalo Therapeutics, IncSold (not open market)$14.2K
May 28, 2026AVTX Avalo Therapeutics, IncSold$10.9K
May 28, 2026AVTX Avalo Therapeutics, IncBought (not open market)—
May 21, 2026AVTX Avalo Therapeutics, IncBought (not open market)—
May 15, 2026AVTX Avalo Therapeutics, IncSold$56.3K
May 15, 2026AVTX Avalo Therapeutics, IncBought (not open market)—
May 6, 2026AVTX Avalo Therapeutics, IncSold$496K
May 6, 2026AVTX Avalo Therapeutics, IncSold$98.3K
May 6, 2026AVTX Avalo Therapeutics, IncSold$953K
May 6, 2026AVTX Avalo Therapeutics, IncSold$426K
May 6, 2026AVTX Avalo Therapeutics, IncSold$230K
May 6, 2026AVTX Avalo Therapeutics, IncBought (not open market)—
May 6, 2026AVTX Avalo Therapeutics, IncBought (not open market)—
May 5, 2026AVTX Avalo Therapeutics, IncSold$26.9K

Companies traded

  • AVTX Avalo Therapeutics, Inc: 16 sales, last Aug 28, 2026
  • CGEM Cullinan Therapeutics, Inc: other filings, last Jun 16, 2026
  • DICE DICE Therapeutics, Inc: other filings, last Aug 9, 2023

Get free alerts when Mittie Doyle files a new trade →